In addition, EMT in renal fibrosis is generally identified by the loss of epithelial proteins, including E-cadherin, ZO-1 and cytokeratin (28,29), and the acquisition of new mesenchymal markers, including vimentin, α-SMA and FSP-1 (30–32). This evidence concerns the gene CDH1 and renal fibrosis.